Marwick Charis A, Guthrie Bruce, Pringle Jan Ec, McLeod Shaun R, Evans Josie Mm, Davey Peter G
Population Health Sciences Division, Medical Research Institute, University of Dundee, Mackenzie Building, Kirsty Semple Way, Dundee DD2 4BF, UK.
BMC Anesthesiol. 2014 Jan 2;14:1. doi: 10.1186/1471-2253-14-1.
Early aggressive therapy can reduce the mortality associated with severe sepsis but this relies on prompt recognition, which is hindered by variation among published severity criteria. Our aim was to test the performance of different severity scores in predicting mortality among a cohort of hospital inpatients with sepsis.
We anonymously linked routine outcome data to a cohort of prospectively identified adult hospital inpatients with sepsis, and used logistic regression to identify associations between mortality and demographic variables, clinical factors including blood culture results, and six sets of severity criteria. We calculated performance characteristics, including area under receiver operating characteristic curves (AUROC), of each set of severity criteria in predicting mortality.
Overall mortality was 19.4% (124/640) at 30 days after sepsis onset. In adjusted analysis, older age (odds ratio 5.79 (95% CI 2.87-11.70) for ≥80y versus <60y), having been admitted as an emergency (OR 3.91 (1.31-11.70) versus electively), and longer inpatient stay prior to sepsis onset (OR 2.90 (1.41-5.94) for >21d versus <4d), were associated with increased 30 day mortality. Being in a surgical or orthopaedic, versus medical, ward was associated with lower mortality (OR 0.47 (0.27-0.81) and 0.26 (0.11-0.63), respectively). Blood culture results (positive vs. negative) were not significantly association with mortality. All severity scores predicted mortality but performance varied. The CURB65 community-acquired pneumonia severity score had the best performance characteristics (sensitivity 81%, specificity 52%, positive predictive value 29%, negative predictive value 92%, for 30 day mortality), including having the largest AUROC curve (0.72, 95% CI 0.67-0.77).
The CURB65 pneumonia severity score outperformed five other severity scores in predicting risk of death among a cohort of hospital inpatients with sepsis. The utility of the CURB65 score for risk-stratifying patients with sepsis in clinical practice will depend on replicating these findings in a validation cohort including patients with sepsis on admission to hospital.
早期积极治疗可降低严重脓毒症相关的死亡率,但这依赖于及时识别,而已发表的严重程度标准存在差异,阻碍了及时识别。我们的目的是测试不同严重程度评分在预测一组脓毒症住院患者死亡率方面的表现。
我们将常规结局数据匿名链接到一组前瞻性确定的成年脓毒症住院患者,并使用逻辑回归来确定死亡率与人口统计学变量、包括血培养结果在内的临床因素以及六套严重程度标准之间的关联。我们计算了每组严重程度标准在预测死亡率方面的表现特征,包括受试者操作特征曲线下面积(AUROC)。
脓毒症发作后30天的总体死亡率为19.4%(124/640)。在多因素分析中,年龄较大(≥80岁与<60岁相比,比值比为5.79(95%CI 2.87-11.70))、急诊入院(比值比为3.91(1.31-11.70)与择期入院相比)以及脓毒症发作前住院时间较长(>21天与<4天相比,比值比为2.90(1.41-5.94))与30天死亡率增加相关。在外科或骨科病房而非内科病房与较低的死亡率相关(比值比分别为0.47(0.27-0.81)和0.26(0.11-0.63))。血培养结果(阳性与阴性)与死亡率无显著关联。所有严重程度评分均能预测死亡率,但表现各异。CURB65社区获得性肺炎严重程度评分具有最佳的表现特征(30天死亡率的敏感性为81%,特异性为52%,阳性预测值为29%,阴性预测值为92%),包括具有最大的AUROC曲线(0.72,95%CI 0.67-0.77)。
在一组脓毒症住院患者中,CURB65肺炎严重程度评分在预测死亡风险方面优于其他五个严重程度评分。CURB65评分在临床实践中对脓毒症患者进行风险分层的实用性将取决于在包括入院时患有脓毒症的患者的验证队列中重复这些发现。